24 results
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
or radioactive substance, hazardous or radioactive material, hazardous or radioactive waste, radiation, asbestos or asbestos containing materials, per … - and polyfluoroalkyl substances, polychlorinated biphenyls, petroleum or petroleum products, and any other waste, substance or material that, due to its
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
or radioactive substance, hazardous or radioactive material, hazardous or radioactive waste, radiation, asbestos or asbestos containing materials, per … - and polyfluoroalkyl substances, polychlorinated biphenyls, petroleum or petroleum products, and any other waste, substance or material that, due to its
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
. 177Lu could avoid the need for clinics to maintain costly dedicated waste streams, providing a unique advantage over the currently approved radioligand … , which necessitates dedicated waste streams and other burdensome overhead for physicians and clinics. POINT believes 177Lu-PNT2003’s use of n.c.a. 177Lu
424B5
PNT
POINT Biopharma Global Inc.
14 Sep 22
Prospectus supplement for primary offering
4:12pm
in outpatient clinics without the need for the clinic to maintain costly dedicated waste streams, providing a unique advantage over the currently
424B5
po9 99jta3
13 Sep 22
Prospectus supplement for primary offering
5:19pm
S-3
m73 z1my0fy5fpmhv
1 Jul 22
Shelf registration
4:13pm
424B3
y7sgj5od
31 Mar 22
Prospectus supplement
11:42am
POS AM
oq0vy
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
bv1 vb8ffzyn
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.1
87t7mw650u 388742abx
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
s3vnt481krl9
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
kf6v7xzeadz xk0
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
d62i5pv bs0r1aw
5 Aug 21
Prospectus supplement
4:26pm
424B3
lcl7jt7x
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.19
rc7u650gl63okf46
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm